1. Hospital registration of adverse drug reactions in electronic health records: importance and contribution to pharmacovigilance
- Author
-
Alloush, Roba, van Lint, Jette, van Marum, Rob J., Hermens, Walter W. A. J. J., Jessurun, Naomi T., Alloush, Roba, van Lint, Jette, van Marum, Rob J., Hermens, Walter W. A. J. J., and Jessurun, Naomi T.
- Abstract
BackgroundInformation on registered adverse drug reactions (ADRs) in hospitals may provide a large real-world data source that can be used to ensure patients' safety. This study aimed to assess the potential contribution of hospital registration of ADRs in electronic health records (EHR) to pharmacovigilance.Research design and methodsAn observational retrospective descriptive study using data from the Jeroen Bosch Hospital in the Netherlands in 2019. 'Serious and/or severe' and 'previously unknown' ADRs registered systematically in the corresponding field of EHRs were assessed.ResultsADR data concerning 1010 patients were included. In total, 1630 ADRs were registered in EHRs. Fifty-eight serious and/or severe ADRs (5.2%) were registered. Tubulointerstitial nephritis was the most frequently registered severe ADR and was mainly associated with antibacterials for systemic use. A total of 82 previously unknown ADRs (5%) were registered. 'Migraine' and 'chest pain' were the most frequently registered unknown ADRs. Additionally, 25 ADRs (1.5%) were registered that may be attributable to 10 drugs 'under additional monitoring.'ConclusionsHospital registrations of ADRs in EHRs provide information on ADRs, which are challenging to assess during clinical trials. However, improvements are required to optimize this registration before it can serve as a valuable data source for pharmacovigilance purposes.
- Published
- 2024